#COVID19: Gilead Sciences Releases Prices For Remdesivir, The COVID-19 Drug

Share to your friends

#COVID19: Gilead Sciences Releases Prices For Remdesivir, The COVID-19 Drug 

Gilead’s CEO, Daniel O’Day has just revealed that a five-day course of remdesivir will cost private health insurers in the US $3,120, and will cost governments of developed nations, including the US, $2,340.

This he said is ready for distribution to different parts of the world.

Go to Source


Share to your friends